Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy
Open Access
- 10 January 2011
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 17 (4) , 423-430
Abstract
Background: Women with multiple sclerosis (MS) are advised to discontinue interferon-beta therapy before trying to conceive. Unplanned pregnancies occur and risks related to exposure remain unclear.Keywords
This publication has 17 references indexed in Scilit:
- Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational studyMultiple Sclerosis Journal, 2009
- Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study)Multiple Sclerosis Journal, 2009
- Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?Journal of Neurology, 2008
- Reproductive counselling, treatment and course of pregnancy in 73 German MS patientsActa Neurologica Scandinavica, 2008
- Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish populationMultiple Sclerosis Journal, 2007
- The reproductive effects of beta interferon therapy in pregnancyNeurology, 2005
- Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosisNeurology, 2005
- PRISMS-4: Long-term efficacy of interferon-β-1a in relapsing MSNeurology, 2001
- Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosisThe Lancet, 1998
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996